Cryo-EM structures of tau filaments from Alzheimer’s disease

Cited by (1,003)

Items 101–200 of 1,003

1. Amyloid assembly and disassembly
   Edward Chuang, Acacia M Hori, Christina D. Hesketh, James Shorter · 2018 · Journal of Cell Science
2. Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
   Yang Shi, Alexey G. Murzin, Benjamin Falcon, Alexander Epstein, Jonathan Machin, Paul A. Tempest, Kathy L. Newell, Rubén Vidal, Holly J. Garringer, Naruhiko Sahara et al. · 2021 · Acta Neuropathologica
3. Acetylation Disfavors Tau Phase Separation
   Ferreon, Josephine C., Jain, Antrix, Choi, Kyoung-Jae, Tsoi, Phoebe S., MacKenzie, Kevin R., Jung, Sung Yun, Ferreon, Allan Chris · 2018 · International Journal of Molecular Sciences
4. CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
   Horie, Kanta, Barthélemy, Nicolas R, Sato, Chihiro, Bateman, Randall J · 2021 · Brain
5. Physical basis of amyloid fibril polymorphism
   William Close, Matthias Neumann, Andreas Schmidt, Manuel Hora, Karthikeyan Annamalai, Matthias Schmidt, Bernd Reif, Volker Schmidt, Nikolaus Grigorieff, Marcus Fändrich · 2018 · Nature Communications
6. Effects of in vivo conditions on amyloid aggregation
   Michael C. Owen, David Gnutt, Mimi Gao, Sebastian K.T.S. Wärmländer, Jüri Jarvet, Astrid Gräslund, Roland Winter, Simon Ebbinghaus, Birgit Strodel · 2019 · Chemical Society Reviews
7. Understanding the invisible hands of sample preparation for cryo-EM
   Giulia Weissenberger, René Henderikx, Peter J. Peters · 2021 · Nature Methods
8. Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
   Kurochkin, Igor V., Guarnera, Enrico, Berezovsky, Igor N. · 2018 · Trends in Pharmacological Sciences
9. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates
   Ioana Mariuca Ilie, Amedeo Caflisch · 2019 · Chemical Reviews
10. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure
    Boyer, David R., Li, Binsen, Sun, Chuanqi, Fan, Weijia, Zhou, Kang, Hughes, Michael P., Sawaya, Michael R., Jiang, Lin, Eisenberg, David S. · 2020 · Proceedings of the National Academy of Sciences
11. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis
    Lynn Radamaker, Yin-Hsi Lin, Karthikeyan Annamalai, Stefanie Huhn, Ute Hegenbart, Stefan Olaf Schönland, Günter Fritz, Matthias Schmidt, Marcus Fändrich · 2019 · Nature Communications
12. Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
    Paolo d’Errico, Melanie Meyer‐Luehmann · 2020 · Frontiers in Aging Neuroscience
13. Transmission of tauopathy strains is independent of their isoform composition
    Zhuohao He, Jennifer D. McBride, Hong Wei Xu, Lakshmi N. Changolkar, Soojung Kim, Bin Zhang, Sneha Narasimhan, Garrett S. Gibbons, Jing Guo, Michael Kozak et al. · 2020 · Nature Communications
14. 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases
    David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Suzanne L. Baker, Viktoriya Bourakova, Adam L. Boxer, Lauren Edwards, Rana April Eser, Maria‐Luisa Gorno‐Tempini, William J. Jagust et al. · 2020 · Brain
15. Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms
    Sofia Giorgetti, Claudio Greco, Paolo Tortora, Francesco A. Aprile · 2018 · International Journal of Molecular Sciences
16. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs
    David R. Boyer, Binsen Li, Chuanqi Sun, Weijia Fan, Michael R. Sawaya, Lin Jiang, David S Eisenberg · 2019 · Nature Structural & Molecular Biology
17. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration
    Eri Saijo, Michael A. Metrick, Shunsuke Koga, Piero Parchi, Irene Litvan, Salvatore Spina, Adam L. Boxer, Julio C. Rojas, Douglas R Galasko, Allison Kraus et al. · 2019 · Acta Neuropathologica
18. The Amyloid Phenomenon and Its Significance in Biology and Medicine
    Christopher Martin Dobson, Tuomas P. J. Knowles, Michele Vendruscolo · 2019 · Cold Spring Harbor Perspectives in Biology
19. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species
    Eliana Nachman, Anne S. Wentink, Karine Madiona, Luc Bousset, Taxiarchis Katsinelos, Kieren S. J. Allinson, Harm H. Kampinga, William A. McEwan, Thomas Robert Jahn, Ronald Melki et al. · 2020 · Journal of Biological Chemistry
20. Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
    Quinn, James P., Corbett, Nicola J., Kellett, Katherine A. B., Hooper, Nigel M. · 2018 · Journal of Alzheimer's Disease
21. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy
    Marcus Fändrich, Sofie Nyström, K. Peter R. Nilsson, Anja Böckmann, Harry LeVine, Per Hammarström · 2018 · Journal of Internal Medicine
22. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
    Ruan, Zhi, Delpech, Jean-Christophe, Venkatesan Kalavai, Srinidhi, Van Enoo, Alicia A., Hu, Jianqiao, Ikezu, Seiko, Ikezu, Tsuneya · 2020 · Molecular Neurodegeneration
23. Conformational Expansion of Tau in Condensates Promotes Irreversible Aggregation
    Jitao Wen, Liu Hong, Georg Krainer, Qiong-Qiong Yao, Tuomas P. J. Knowles, Si Wu, Sarah Perrett · 2021 · Journal of the American Chemical Society
24. Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
    Galina Limorenko, Hilal Ahmed Lashuel · 2021 · Chemical Society Reviews
25. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
    Paolo Swuec, Francesca Lavatelli, Masayoshi Tasaki, Cristina Paissoni, Paola Rognoni, Martina Maritan, Francesca Brambilla, Paolo Milani, Pierluigi Mauri, Carlo Camilloni et al. · 2019 · Nature Communications
26. 2.7 Å cryo-EM structure of ex vivo RML prion fibrils
    Szymon W. Manka, Wenjuan Zhang, Adam Wenborn, Jemma K. Betts, Susan Joiner, Helen R. Saibil, John Collinge, Jonathan D. F. Wadsworth · 2022 · Nature Communications
27. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
    Yi Xiao Jiang, Qin Cao, Michael R. Sawaya, Romany N. N. Abskharon, Peng Ge, Michael A. Deture, Dennis W. Dickson, Janine Y. Fu, Rachel R. Ogorzalek Loo, Joseph A. Loo et al. · 2022 · Nature
28. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies
    Jie Xiang, Youqi Tao, Yiyuan Xia, Shilin Luo, Qinyue Zhao, Bowei Li, Xiaoqian Zhang, Yunpeng Sun, Wencheng Xia, Mingming Zhang et al. · 2023 · Cell
29. Monomer-dependent secondary nucleation in amyloid formation
    Sara Snogerup Linse · 2017 · Biophysical Reviews
30. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins
    Grant T. Corbett, Zemin Wang, Wei Hong, Martí Colom‐Cadena, Jamie L. Rose, Meichen Liao, Adhana Asfaw, Tia C. Hall, Lai Ding, Alexandra DeSousa et al. · 2019 · Acta Neuropathologica
31. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43
    Qiuye Li, W. Michael Babinchak, Witold K. Surewicz · 2021 · Nature Communications
32. Approaches to altering particle distributions in cryo-electron microscopy sample preparation
    Ieva Drulyte, Rachel M. Johnson, Emma L. Hesketh, Daniel L. Hurdiss, Charlotte A. Scarff, Alin Sebastian Porav, Neil A. Ranson, Stephen P. Muench, Rebecca F. Thompson · 2018 · Acta Crystallographica Section D Structural Biology
33. FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
    Novak, Petr, Schmidt, Reinhold, Kontsekova, Eva, Kovacech, Branislav, Smolek, Tomas, Katina, Stanislav, Fialova, Lubica, Prcina, Michal, Parrak, Vojtech, Dal-Bianco, Peter et al. · 2018 · Alzheimer's Research & Therapy
34. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
    Chang, Andrew, Xiang, Xinyu, Wang, Jing, Lee, Carolyn, Arakhamia, Tamta, Simjanoska, Marija, Wang, Chi, Carlomagno, Yari, Zhang, Guoan, Dhingra, Shikhar et al. · 2022 · Cell
35. Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau
    Cabrales Fontela, Yunior, Kadavath, Harindranath, Biernat, Jacek, Riedel, Dietmar, Mandelkow, Eckhard, Zweckstetter, Markus · 2017 · Nature Communications
36. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
    Zhening Zhang, Wenguang G. Liang, Lucas J. Bailey, Yong Zi Tan, Hui Wei, Andrew Wang, Mara Farcasanu, Virgil A. Woods, Lauren A. McCord, David E. Lee et al. · 2018 · eLife
37. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids
    Falk Liberta, Sarah Loerch, Matthies Rennegarbe, Angelika Schierhorn, Per Westermark, Gunilla Torstensdotter Westermark, Bouke P. C. Hazenberg, Nikolaus Grigorieff, Marcus Fändrich, Matthias Schmidt · 2019 · Nature Communications
38. Cell-to-Cell Transmission of Tau and α-Synuclein
    Uemura, Norihito, Uemura, Maiko T., Luk, Kelvin C., Lee, Virginia M.-Y., Trojanowski, John Q. · 2020 · Trends in Molecular Medicine
39. An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
    Carlomagno, Yari, Chung, Dah-eun Chloe, Yue, Mei, Castanedes-Casey, Monica, Madden, Benjamin J., Dunmore, Judy, Tong, Jimei, DeTure, Michael, Dickson, Dennis W., Petrucelli, Leonard et al. · 2017 · Journal of Biological Chemistry
40. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
    Kraus, Allison, Saijo, Eri, Metrick, Michael A., Newell, Kathy, Sigurdson, Christina J., Zanusso, Gianluigi, Ghetti, Bernardino, Caughey, Byron · 2019 · Acta Neuropathologica
41. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
    Paul J. Derry, Muralidhar L. Hegde, George R. Jackson, Rakez Kayed, James M. Tour, Ah-Lim Tsai, Thomas A. Kent · 2019 · Progress in Neurobiology
42. Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
    Kun Zhao, Yaowang Li, Zhenying Liu, Houfang Long, Chunyu Zhao, Feng Luo, Yunpeng Sun, Youqi Tao, Xiao‐Dong Su, Dan Li et al. · 2020 · Nature Communications
43. Tau strains shape disease
    Jaime Vaquer‐Alicea, Marc I. Diamond, Łukasz A. Joachimiak · 2021 · Acta Neuropathologica
44. The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism
    Matthew G. Iadanza, Robert Silvers, Joshua Boardman, Hugh I. Smith, Theodoros K. Karamanos, Galia T. Debelouchina, Yongchao Su, Robert G. Griffin, Neil A. Ranson, Sheena E. Radford · 2018 · Nature Communications
45. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies
    Strang, Kevin H., Croft, Cara L., Sorrentino, Zachary A., Chakrabarty, Paramita, Golde, Todd E., Giasson, Benoit I. · 2018 · Journal of Biological Chemistry
46. Tau positron emission tomography imaging in tauopathies: The added hurdle of off‐target binding
    Laëtitia Lemoine, Antoine Leuzy, Konstantinos Chiotis, Elena Rodriguez‐Vieitez, Agneta K. Nordberg · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
47. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils
    Qin Cao, David R. Boyer, Michael R. Sawaya, Peng Ge, David S Eisenberg · 2020 · Nature Structural & Molecular Biology
48. Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
    Niyatee P. Samudra, Courtney Lane‐Donovan, Lawren A. VandeVrede, Adam L. Boxer · 2023 · Journal of Clinical Investigation
49. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease
    Roberts, Malcolm, Sevastou, Ioanna, Imaizumi, Yoichi, Mistry, Kavita, Talma, Sonia, Dey, Madhurima, Gartlon, Jane, Ochiai, Hiroshi, Zhou, Zhi, Akasofu, Shigeru et al. · 2020 · Acta Neuropathologica Communications
50. Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations
    Xiaodan Ni, Ryan P. McGlinchey, Jiansen Jiang, Jennifer C. Lee · 2019 · Journal of Molecular Biology
51. New Insights Into Drug Discovery Targeting Tau Protein
    Yoshiyuki Soeda, Akihiko Takashima · 2020 · Frontiers in Molecular Neuroscience
52. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
    Ping, Lingyan, Kundinger, Sean R., Duong, Duc M., Yin, Luming, Gearing, Marla, Lah, James J., Levey, Allan I., Seyfried, Nicholas T. · 2020 · Scientific Data
53. Functional Amyloid and Other Protein Fibers in the Biofilm Matrix
    E. Erskine, C. MacPhee, N. Stanley-Wall · 2018 · Journal of Molecular Biology
54. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
    Jean‐Philippe Courade, Rachel C. Angers, Georges Mairet‐Coello, Nathalie Pacico, Kerry L. Tyson, Daniel J. Lightwood, Rebecca Munro, David McMillan, Robert Griffin, TERRY S. BAKER et al. · 2018 · Acta Neuropathologica
55. Cryo-EM of amyloid fibrils and cellular aggregates
    Anthony W. P. Fitzpatrick, Helen R. Saibil · 2019 · Current Opinion in Structural Biology
56. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases
    Dillon J. Rinauro, Fabrizio Chiti, Michele Vendruscolo, Ryan Limbocker · 2024 · Molecular Neurodegeneration
57. Cofactors are essential constituents of stable and seeding-active tau fibrils
    Fichou, Yann, Lin, Yanxian, Rauch, Jennifer N., Vigers, Michael, Zeng, Zhikai, Srivastava, Madhur, Keller, Timothy J., Freed, Jack H., Kosik, Kenneth S., Han, Songi · 2018 · Proceedings of the National Academy of Sciences
58. Tau filaments in neurodegenerative diseases
    Goedert, Michel · 2018 · FEBS Letters
59. In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
    Meisl, Georg, Hidari, Eric, Allinson, Kieren, Rittman, Timothy, DeVos, Sarah L., Sanchez, Justin S., Xu, Catherine K., Duff, Karen E., Johnson, Keith A., Rowe, James B. et al. · 2021 · Science Advances
60. Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores
    Peter Verwilst, Hyeong Seok Kim, Soobin Kim, Chulhun Kang, Jong Seung Kim · 2018 · Chemical Society Reviews
61. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo
    Cristina Vergara, Sarah Houben, Valérie Suain, Zehra Yilmaz, Robert De Decker, Virginie Vanden Dries, Alain Boom, Salwa Mansour, Karelle Leroy, Kunié Ando et al. · 2018 · Acta Neuropathologica
62. Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition
    Devesh Tewari, Archana Negi Sah, Sweta Bawari, Seyed Fazel Nabavi, Ahmad Reza Dehpour, Samira Shirooie, Nady Braidy, Bernd L. Fiebich, Rosa Anna Vacca, Seyed Mohammad Nabavi · 2020 · Current Neuropharmacology
63. Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease
    Sandeep K. Rai, Adriana Savastano, Priyanka Singh, Samrat Mukhopadhyay, Markus Zweckstetter · 2021 · Protein Science
64. Orchestration of selective autophagy by cargo receptors
    Elias Adriaenssens, Luca Ferrari, Sascha Martens · 2022 · Current Biology
65. The proline-rich domain promotes Tau liquid–liquid phase separation in cells
    Xuemei Zhang, Michael P. Vigers, James McCarty, Jennifer N. Rauch, Glenn H. Fredrickson, Maxwell Z. Wilson, Joan‐Emma Shea, Songi Han, Kenneth S. Kosik · 2020 · The Journal of Cell Biology
66. Microglia in Alzheimer’s Disease in the Context of Tau Pathology
    Juan Ramón Perea, Marta Bolós, Jesús Ávila · 2020 · Biomolecules
67. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
    Dan Li, Cong Liu · 2022 · Nature reviews. Neuroscience
68. Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism
    Cooper, Joanna M., Lathuiliere, Aurelien, Migliorini, Mary, Arai, Allison L., Wani, Mashhood M., Dujardin, Simon, Muratoglu, Selen C., Hyman, Bradley T., Strickland, Dudley K. · 2021 · Journal of Biological Chemistry
69. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
    Ashton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R. et al. · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
70. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases
    Michael A. Metrick, Natalia Ferreira, Eri Saijo, Allison Kraus, Kathy L. Newell, Gianluigi Zanusso, Michele Vendruscolo, Bernardino Francesco Ghetti, Byron W. Caughey · 2020 · Acta Neuropathologica Communications
71. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases
    Hironobu Endo, Maiko Ono, Yuhei Takado, Kiwamu Matsuoka, Manami Takahashi, Kenji Tagai, Yuko Kataoka, Kosei Hirata, Keisuke Takahata, Chie Seki et al. · 2024 · Neuron
72. Structure-based inhibitors of amyloid beta core suggest a common interface with tau
    Griner, Sarah L, Seidler, Paul, Bowler, Jeannette, Murray, Kevin A, Yang, Tianxiao Peter, Sahay, Shruti, Sawaya, Michael R, Cascio, Duilio, Rodriguez, Jose A, Philipp, Stephan et al. · 2019 · eLife
73. Tuning protein assembly pathways through superfast amyloid-like aggregation
    Chen Li, Lu Xu, Yi Y. Zuo, Peng Yang · 2018 · Biomaterials Science
74. Regulation of liquid–liquid phase separation with focus on post-translational modifications
    Yun-Yi Luo, Jun Wu, Yanmei Li · 2021 · Chemical Communications
75. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
    Yun Sik Yang, Vı́ctor Tapias, Diana M. Acosta, Hui Xu, Huan‐Lian Chen, Ruchika P. Bhawal, Elizabeth T. Anderson, Elena Ivanova, Hening Lin, Botir T. Sagdullaev et al. · 2022 · Nature Communications
76. Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2
    Elizabeth L. Guenther, Peng Ge, Hamilton Trinh, Michael R. Sawaya, Duilio Cascio, David R. Boyer, Tamir Gonen, Z. Hong Zhou, David S Eisenberg · 2018 · Nature Structural & Molecular Biology
77. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson’s disease
    Guilherme A. P. de Oliveira, Jerson Lima Silva · 2019 · Communications Biology
78. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease
    Shengnan Zhang, Yuqing Liu, Chunyu Jia, Yeh‐Jun Lim, Guoqin Feng, Enquan Xu, Houfang Long, Yasuyoshi Kimura, Youqi Tao, Chunyu Zhao et al. · 2021 · Proceedings of the National Academy of Sciences
79. Synaptic tau: A pathological or physiological phenomenon?
    Miranda Robbins, Emma L. Clayton, Gabriele S. Kaminski Schierle · 2021 · Acta Neuropathologica Communications
80. Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
    Shanya Jiang, Kiran Bhaskar · 2020 · Frontiers in Molecular Neuroscience
81. Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
    Botond Penke, Mária Szűcs, Ferenc Bogár · 2020 · Molecules
82. AADvac1, an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development
    Petr Novák, Norbert Žilka, Monika Žilková, Branislav Kováčech, Rostislav Škrabana, Matej Ondrus, L Fialová, Eva Kontseková, Markus Otto, M Novák · 2019 · The Journal of Prevention of Alzheimer s Disease
83. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports
    Hilal Ahmed Lashuel · 2020 · Neurobiology of Disease
84. The informed road map to prevention of Alzheimer Disease: a call to arms
    McDade, Eric, Llibre-Guerra, Jorge J., Holtzman, David M., Morris, John C., Bateman, Randall J. · 2021 · Molecular Neurodegeneration
85. Hidden motions and motion-induced invisibility: Dynamics-based spectral editing in solid-state NMR
    Irina Matlahov, Patrick C.A. van der Wel · 2018 · Methods
86. Peptide Amyloids in the Origin of Life
    Jason Greenwald, Witek Kwiatkowski, Roland Riek · 2018 · Journal of Molecular Biology
87. Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
    Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martínez‐González, Carlos Roca, Nuria Eugenia Campillo, Josefa Zaldívar-Díez, Concepción Pérez, Giampaolo Zuccheri, Andrea Miti et al. · 2018 · Journal of Medicinal Chemistry
88. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases
    Klara Kulenkampff, Adriana-M. Wolf Perez, Pietro Sormanni, Johnny Habchi, Michele Vendruscolo · 2021 · Nature Reviews Chemistry
89. Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition
    Sushma Subedi, Santanu Sasidharan, Niharika Nag, Prakash Saudagar, Timir Tripathi · 2022 · Molecules
90. Folding or holding?—Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease
    Benjamin S. Rutledge, Wing‐Yiu Choy, Martin L. Duennwald · 2022 · Journal of Biological Chemistry
91. Galectin-8–mediated selective autophagy protects against seeded tau aggregation
    Benjamin Falcon, Jessica Noad, Harvey T. McMahon, Felix Randow, Michel Goedert · 2017 · Journal of Biological Chemistry
92. Structural and Functional Insights into α-Synuclein Fibril Polymorphism
    Surabhi Mehra, Laxmikant G. Gadhe, Riya Bera, Ajay Singh Sawner, Samir Kumar Maji · 2021 · Biomolecules
93. Solid-State NMR: Methods for Biological Solids
    Sahil Ahlawat, Kaustubh R. Mote, Nils‐Alexander Lakomek, Vipin Agarwal · 2022 · Chemical Reviews
94. Protein misfolding and amyloid nucleation through liquid–liquid phase separation
    Semanti Mukherjee, Manisha Poudyal, Kritika Dave, Pradeep Kadu, Samir Kumar Maji · 2024 · Chemical Society Reviews
95. CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
    Madeleine A. G. Gilbert, Nayab Fatima, Joshua Jenkins, Thomas J. O’Sullivan, Andreas Schertel, Yehuda Halfon, Martin Wilkinson, Tjado H. J. Morrema, Mirjam Geibel, Randy J. Read et al. · 2024 · Nature
96. The Protein Disulfide Isomerase Family: from proteostasis to pathogenesis
    Motonori Matsusaki, Shingo Kanemura, Misaki Kinoshita, Young‐Ho Lee, Kenji Inaba, Masaki Okumura · 2019 · Biochimica et Biophysica Acta (BBA) - General Subjects
97. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly
    Rodrigo U. Gallardo, Matthew G. Iadanza, Yong Xu, George R. Heath, Richard Foster, Sheena E. Radford, Neil A. Ranson · 2020 · Nature Structural & Molecular Biology
98. Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease
    Stephanie L. Fowler, Tiana S. Behr, Emir Turkes, Darragh Patrick O'Brien, Paula Maglio Cauhy, Isadora Rawlinson, Marisa J. Edmonds, Martha S. Foiani, Ari W. Schaler, Gerard Crowley et al. · 2024 · Nature Neuroscience
99. Progressive supranuclear palsy: Advances in diagnosis and management
    David G. Coughlin, Irene Litvan · 2020 · Parkinsonism & Related Disorders
100. CryoEM structure of the low-complexity domain of hnRNPA2 and its conversion to pathogenic amyloid
     Jiahui Lu, Qin Cao, Michael P. Hughes, Michael R. Sawaya, David R. Boyer, Duilio Cascio, David S Eisenberg · 2020 · Nature Communications